What is Depression Phase 2 Ketamine Clinical Trial?
Category: Others
Depression Phase 2 Ketamine Clinical Trial is an interventional study to determine whether specific doses of ketamine are superior to placebo therapy in treatment resistant depression. Identifier: NCT01920555
| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Major depressive disorder | 2 | 0 |
- Major
- Moderate
- Slight
- None
- Can't tell
Why patients stopped taking Depression Phase 2 Ketamine Clinical Trial
Multiple reasons could be selected
| Reason | Patients | Percentage |
|---|---|---|
| Course of treatment ended | 1 |
Duration
Stopped using Depression Phase 2 Ketamine Clinical Trial
| Duration | Patients | Percentage |
|---|---|---|
| Less than 1 month | 1 |
Last updated: